Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...

Merck & Co – known as MSD outside the US and Canada – has received approval from the Medicines and Healthcare products ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s (NYSE:MRK) Welireg (belzutifan) for ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects ...

FRANKFURT (Reuters) -German pharmaceutical and specialty materials group Merck KGaA on Thursday guided more cautiously for ...

Shares fell after the company cut its full-year guidance on the back of challenging macroeconomic conditions and ...

May 14, 2025 US FDA expands use of Merck's cancer drug for adrenal gland tumors The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to ...

4 analysts have shared their evaluations of Merck & Co (NYSE:MRK) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a concise overview ...

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s (NYSE:MRK) Welireg (belzutifan) for adult and pediatric patients 12 years and older with locally advanced ...